Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration

Journal of Clinical Pharmacology

Volumn 47, Issue 1, 2007, Pages 94-100

  Mannila, Anne ^a   Kumpulainen, Elina ^a,b   Lehtonen, Marko ^a   Heikkinen, Marja ^b   Laisalmi, Merja ^b   Salo, Terhi ^a   Rautio, Jarkko ^a   Savolainen, Jouko ^a   Kokki, Hannu ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Central nervous system; Cerebrospinal fluid; Children; Indomethacin

Indexed keywords

INDOMETACIN; PLASMA PROTEIN;

ABDOMINAL PAIN; AGITATION; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DETERMINATION; DRUG PENETRATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NAUSEA; NORMAL HUMAN; PREOPERATIVE TREATMENT; SHIVERING; SIDE EFFECT; SINGLE DRUG DOSE; SPINAL ANESTHESIA; VOMITING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INDOMETHACIN; INFANT; INFUSIONS, INTRAVENOUS; MALE; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 33845796043     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270006295202     Document Type: Article

References (31)

1. Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med. 2005 ; 10: 177-184.
2. Maunuksela EL, Olkkola KT, Korpela R. Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children? Can J Anaesth. 1988 ; 35: 123-127.
3. Ossipov MH, Jerussi TP, Ren K, Sun H, Porreca F. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain. 2000 ; 87: 193-199.
4. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 1992 ; 263: 136-146.
5. Daher JB, Tonussi CR. A spinal mechanism for the peripheral anti-inflammatory action of indomethacin. Brain Res. 2003 ; 962: 207-212.
6. Reinold H, Ahmadi S, Depner UB, et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest. 2005 ; 115: 673-679.
7. Bannwarth B, Netter P, Lapicque F, Pere P, Thomas P, Gaucher A. Plasma and cerebrospinal fluid concentrations of indomethacin in humans: relationship to analgesic activity. Eur J Clin Pharmacol. 1990 ; 38: 343-346.
8. Clunie M, Crone LA, Klassen L, Yip R. Psychiatric side effects of indomethacin in parturients. Can J Anaesth. 2003 ; 50: 586-588.
9. Tharumaratnam D, Bashford S, Khan SA. Indomethacin induced psychosis. Postgrad Med J. 2000 ; 76: 736-737.
10. Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs: aseptic meningitis, psychosis, and cognitive dysfunction. Arch Intern Med. 1991 ; 151: 1309-1313.
11. Dittrich P, Kohler G, Primbs P, Kukovetz WR. Pharmacokinetics of indomethacin i.m. in blood, synovial fluid, synovial membrane, muscle, fat, bone, and spinal fluid. Eur J Rheumatol Inflamm. 1984 ; 7: 45-50.
12. Leis HJ, Leis M, Windischhofer W. Stable isotope labelling and determination of ketroprofen in human plasma and urine by gas chromatography/negative ion chemical ionization mass spectrometry. J Mass Spectrom. 1996 ; 31: 486-492.
13. Mannila A, Kokki H, Heikkinen M, et al. Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young children. Clin Pharmacokinet. 2006 ; 45: 737-743.
14. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol. 2002 ; 42: 553-583.
15. van der Marel CD, Anderson BJ, Pluim MA, de Jong TH, Gonzalez A, Tibboel D. Acetaminophen in cerebrospinal fluid in children. Eur J Clin Pharmacol. 2003 ; 59: 297-302.
16. Johr M. Postanaesthesia excitation. Paediatr Anaesth. 2002 ; 12: 293-295.
17. Kokki H, Hendolin H. Comparison of spinal anaesthesia with epidural anaesthesia in paediatric surgery. Acta Anaesthesiol Scand. 1995 ; 39: 896-900.
18. Pardridge WM. Transport of small molecules through the blood-brain barrier: biology and methodology. Adv Drug Deliv Rev. 1995 ; 15: 5-36.
19. Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos. 2002 ; 30: 1497-1503.
20. Ohtsuki S, Asaba H, Takanaga H, et al. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem. 2002 ; 83: 57-66.
21. Kusuhara H, Sugiyama Y. Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv Drug Deliv Rev. 2004 ; 56: 1741-1763.
22. Mori S, Ohtsuki S, Takanaga H, Kikkawa T, Kang YS, Terasaki T. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem. 2004 ; 90: 931-941.
23. Zhang Y, Schuetz JD, Elmquist WF, Miller DW. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J Pharmacol Exp Ther. 2004 ; 311: 449-455.
24. Kusuhara H, Sugiyama Y. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx. 2005 ; 2: 73-85.
25. Reid G, Wielinga P, Zelcer N, et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 2003 ; 100: 9244-9249.
26. Dallas S, Schlichter L, Bendayan R. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonyl-methoxyethyl)adenine by microglia. J Pharmacol Exp Ther. 2004 ; 309: 1221-1229.
27. Apiwattanakul N, Sekine T, Chairoungdua A, et al. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol. 1999 ; 55: 847-854.
28. Khamdang S, Takeda M, Noshiro R, et al. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 2002 ; 303: 534-539.
29. Shitara Y, Sugiyama D, Kusuhara H, et al. Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)and Oatp2 (Slc21a5)-mediated transport. Pharm Res. 2002 ; 19: 147-153.
30. Rowland M, Tozer TN. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins: 1995.
31. Muller N, Lapicque F, Monot C, et al. Protein binding of indomethacin in human cerebrospinal fluid. Biochem Pharmacol. 1991 ; 42: 799-804.